RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
+1.25%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$1.99B
AUM Growth
+$1.99B
(+4.3%)
Cap. Flow
+$130M
Cap. Flow
% of AUM
6.57%
Top 10 Holdings %
Top 10 Hldgs %
40.54%
Holding
101
New
13
Increased
27
Reduced
12
Closed
14
Top Buys
| 1 |
Mativ Holdings
MATV
|
$54.2M |
| 2 |
DEN
Denbury Inc.
DEN
|
$48.2M |
| 3 |
Noble Corp
NE
|
$43M |
| 4 |
Green Plains
GPRE
|
$29.8M |
| 5 |
Valaris
VAL
|
$28.2M |
Top Sells
| 1 |
RDUS
Radius Health, Inc.
RDUS
|
$72.2M |
| 2 |
Greif
GEF
|
$37.4M |
| 3 |
Insmed
INSM
|
$25.4M |
| 4 |
BRSL
Brightstar Lottery PLC
BRSL
|
$23.9M |
| 5 |
IEA
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
|
$22.6M |
Sector Composition
| 1 | Healthcare | 23.08% |
| 2 | Industrials | 19.95% |
| 3 | Energy | 18.9% |
| 4 | Financials | 10.05% |
| 5 | Materials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMYT
26
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $24.9M | 1.25% |
3,600,000
| – | – |
|
27
Clear Channel Outdoor Holdings
CCO
$636M
| $23.8M | 1.2% |
17,391,427
| – | – |
|
28
Dole
DOLE
$1.4B
| $23.7M | 1.19% |
+3,249,589
| New | +$23.7M |
|
29
Koppers
KOP
$554M
| $23.6M | 1.19% |
1,133,840
| – | – |
|
|
HRT
30
DELISTED
HireRight Holdings Corporation
HRT
| $23.2M | 1.17% |
1,523,266
| – | – |
|
31
Bausch Health
BHC
$2.72B
| $22.5M | 1.13% |
+3,264,471
| New | +$22.5M |
|
32
Karyopharm Therapeutics
KPTI
$61.4M
| $21.8M | 1.1% |
3,990,126
-409,874
| -9% | -$2.24M |
|
33
Magnachip Semiconductor
MX
$107M
| $20M | 1.01% |
1,950,100
| – | – |
|
|
KDNY
34
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $18.7M | 0.94% |
949,166
| – | – |
|
35
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $18.6M | 0.94% |
1,446,107
+922,579
| +176% | +$11.8M |
|
36
Digimarc
DMRC
$171M
| $16.5M | 0.83% |
1,214,593
| – | – |
|
37
QuinStreet
QNST
$875M
| $14.3M | 0.72% |
1,360,683
-225,241
| -14% | -$2.37M |
|
38
ARS Pharmaceuticals
SPRY
$1.08B
| $14.2M | 0.72% |
2,695,170
+1,708,717
| +173% | +$9.02M |
|
|
FREE
39
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $13.8M | 0.69% |
3,583,363
| – | – |
|
40
ReNew
RNW
$2.78B
| $13.7M | 0.69% |
2,279,013
| – | – |
|
|
AVEO
41
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $13.7M | 0.69% |
1,664,667
+740,782
| +80% | +$6.1M |
|
|
CMRX
42
DELISTED
Chimerix, Inc.
CMRX
| $12.8M | 0.64% |
6,625,000
-459,604
| -6% | -$887K |
|
|
NGM
43
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $11.5M | 0.58% |
877,161
+79,573
| +10% | +$1.04M |
|
44
Telesat
TSAT
$307M
| $11M | 0.55% |
1,410,000
| – | – |
|
45
Heron Therapeutics
HRTX
$204M
| $10.6M | 0.53% |
+2,516,328
| New | +$10.6M |
|
46
ANI Pharmaceuticals
ANIP
$2.06B
| $9.23M | 0.46% |
287,046
+204,602
| +248% | +$6.58M |
|
47
Arcutis Biotherapeutics
ARQT
$1.91B
| $9.02M | 0.45% |
472,047
+245,701
| +109% | +$4.7M |
|
|
MREO
48
Mereo BioPharma
MREO
$275M
| $8.93M | 0.45% |
10,366,120
-6,390,000
| -38% | -$5.5M |
|
49
Trevi Therapeutics
TRVI
$871M
| $8.75M | 0.44% |
5,684,420
+3,906,000
| +220% | +$6.02M |
|
50
Alector
ALEC
$282M
| $8.51M | 0.43% |
900,000
| – | – |
|